Cumberland Pharmaceuticals Inc (CPIX) Q3 2024 Earnings Call Highlights: Navigating Challenges ... [Yahoo! Finance]
Cumberland Pharmaceuticals Inc. (CPIX)
Last cumberland pharmaceuticals inc. earnings: 3/18 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.shareholder.com/cpix/index.cfm
Company Research
Source: Yahoo! Finance
Year-to-Date Net Revenue: $27 million. Gross Margin: Improved to 85% during the quarter. Total Operating Expenses: $10.8 million for Q3 2024, a $1 million improvement over the prior year. Net Loss: $1.5 million for the quarter. Adjusted Loss: $0.26 million or 2 per share. Total Assets: $76.7 million as of September 30, 2024. Cash and Cash Equivalents: $17.5 million. Total Liabilities: $52.3 million. Shareholders' Equity: $24.8 million. Credit Facility: $16 million drawn from a $20 million line of credit. Share Repurchase Program: 72,000 shares repurchased in Q3, 275,000 shares year-to-date. Tax Net Operating Loss Carryforwards: Over $52 million. Warning! GuruFocus has detected 3 Warning Signs with CPIX. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Cumberland Pharmaceuticals Inc ( NASDAQ:CPIX ) reported $9.1 million in net revenue for the third quarter, with strong perf
Show less
Read more
Impact Snapshot
Event Time:
CPIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPIX alerts
High impacting Cumberland Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
CPIX
News
- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cumberland Pharmaceuticals Third Quarter 2024 Earnings: US$0.11 loss per share (vs US$0.073 loss in 3Q 2023) [Yahoo! Finance]Yahoo! Finance
- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company UpdatePR Newswire
- CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY [Yahoo! Finance]Yahoo! Finance
CPIX
Sec Filings
- 11/12/24 - Form 8-K
- 11/8/24 - Form 10-Q
- 11/7/24 - Form 8-K
- CPIX's page on the SEC website